Abstract Guidelines

Before submitting your abstract, please carefully read the following information and instructions. If you have any questions, contact the ASM Microbe Programming Team for assistance.

General Guidelines (All Submissions)
  • It is preferred that ASM Microbe 2024 be the first major presentation of the abstract.
  • A presenter may be a presenter on more than 1 abstract.
  • Programming decisions are considered final.
  • Abstracts must be well written and easy to understand.
  • Approval of all co-authors must be obtained before placing their names on an abstract.
  • Submission of multiple overlapping abstracts is discouraged.
Guidelines for Clinical Tracks (AAR, CPHM, CIV, POM)
  • The reason for the study, or how the study came about (e.g. hypothesis, discovery or central question), should be clearly stated.
  • Methods must be included.
  • Data must be objectively gathered, analyzed and reported.
  • Data must support the stated conclusion(s).
  • All presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-U.S. IND or non-U.S. early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s to describe new compounds and their properties and that chemical structures of lead compounds will be included as part of the poster presentation).
Note: Any posters or talks dealing with a specific small molecule antimicrobial agent must provide a chemical structure, or a literature reference to the structure, in order to be presented at the meeting. Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.

Scientific presentations at ASM Microbe 2024 will be expected to transparently report a study’s scientific rigor, including, but not limited to, the following: 1) experimental design; 2) methodology; 3) data collection; 4) analysis and 5) interpretation and report of results. Other key components of scientific rigor, if applicable, include, sample size, randomization, blinding and replication.
Guidelines for Basic Science Tracks (AES, EEB, HMB, MBP)
  • The reason for the study or how the study came about, (e.g. hypothesis, discovery or central question) should be clearly stated.
  • Data must be objectively gathered, analyzed and reported.
  • Data must support the stated conclusion(s).
  • Conclusion(s) should be made, but the study does not need to be fully complete (the standard to present at ASM Microbe is not the same as to publish in a journal).
  • Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.
  • Scientific presentations at ASM Microbe 2024 will be expected to transparently report a study’s scientific rigor, including, but not limited to, the following: 1) experimental design and 2) interpretation and report of results.
Abstract Formatting

Abstract Title

Please use a short and concise title that indicates the content of the abstract. (Please note: The title is not included in the total character count of 2,200). 

Abstract Body Text

  • Your abstract may have up to 2,200 characters, which does not include title, authors, groups and affiliations.
  • Tables and graphics (maximum of 500 characters) are not included in the character count.
  • Spaces are not counted. Do not include abstract title, authors or keywords in abstract text.
  • Abstract text may be submitted using the following methods: either copy/paste, direct entry keystrokes or file upload.
  • Your abstract may be written without the use of the following bolded headers: Background, Methods, Results, Conclusion.
  • Follow the abstract guidelines to ensure all required information about your study is provided in your abstract. 

Author Information

Author(s)'s name(s), institution(s), location(s), title(s). 

CE Disclosures
Relative to this activity, instructors, planners, content reviewers and managers who affect the content of a CME/CE activity are required to disclose relevant financial relationships they have with commercial interests (i.e., any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients).

For more detailed information and step-by-step instructions on how to submit your abstract for ASM Microbe 2024, please visit the abstract submission site.
Abstract Embargo Policy
All ASM Microbe abstracts will be embargoed until June 13, 2024. Some abstracts will be embargoed to coincide with the times they are presented at the meeting. Embargo times and dates will be clearly marked on all press releases.
 
Additionally, press releases and other promotional activity by third parties must coincide with the date and time of the presentation.
Plagiarism Policy
Plagiarism will not be tolerated in submitted abstracts. All submitted abstracts identified with plagiarism will be sent to the ASM Ethics Committee for review and handling. Please refer to the ASM Ethics Code of Conduct for details.


Ready to Submit Your Abstract?
Submit Now


Technical Support

If you have any questions regarding use of the abstract submission site, please contact technical support at asm@support.ctimeetingtech.com.